Ledger.Open graph →
SEC Form D · filed November 15, 2017

X4 Pharmaceuticals, Inc

Offering
$30.0M
Sold
$25.8M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Cambidge, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

John Celebi · Cambrdge, MAExecPaula Ragan · Belmont, MAExec · DirectorAlan E. Walts · Cambridge, MAExec · DirectorMichael Gilman · Belmont, MADirectorNancy Lurker · Cambridge, MADirectorIsaac Blech · Cambridge, MADirectorHugh J. Notman · Gatineau, Quebec, CanadaExec · DirectorTimothy J. Mccunn · Gatineau, Quebec, CanadaDirectorSteven Archambault · Gatineau, Quebec, CanadaExec · DirectorPaul J. Smith · Gatineau, Quebec, CanadaDirectorSudha Parasuraman · Cambridge, MAExecAndrea K. Franz · Cambridge, MAExecTodd Slattery · New York, NYExec · DirectorDavid Blumer · New York, NYExec · DirectorCathleen Ellsworth · Greenwich, CTDirectorJustin L. Bertram · PITTSBURGH, PADirectorSudha Parasuraman · Cambridge, MAExecAndrea K. Franz · Cambridge, MAExecJohn Celebi · Cambrdge, MAExecNancy Lurker · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗